Back to News
Market Impact: 0.22
IDEXX Stock Gains Following the Acquisition of CoVet
Source: zacks.com
M&A & RestructuringArtificial IntelligenceTechnology & InnovationHealthcare & Biotech
IDEXX Laboratories shares rose 0.6% after the company acquired CoVet, an AI-native software provider. The acquisition expands IDEXX's capabilities in veterinary workflows, diagnostics and practice-performance tools, supporting its technology offering in the veterinary market.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.32
Ticker Sentiment
IDXX0.58
More News
- California AG Says Paramount-WBD Merger Would Hurt the State
- Australia’s central bank chief warns inflation risks materialising
- Asian stocks rise as oil retreat eases inflation fears, BOJ in focus
- California AG Bonta on Paramount-Warner Bros., Meta and AI
- A breakout in the 10-year Treasury yield could hold back stocks if it reaches this level
- Fed rate decision and Warsh comments roiled markets. Where to find opportunities